Weill Cornell scientists have discovered that free radicals from astrocyte mitochondria drive brain inflammation linked to dementia. Using new S3QEL compounds, researchers blocked these radicals at their source, slowing neuronal damage in mice. The breakthrough offers a promising path for treating Alzheimer's and frontotemporal dementia by targeting brain degeneration precisely.